Improved treatment satisfaction in patients with type 2 diabetes treated with once‐weekly semaglutide in the SUSTAIN trials

AIM: To investigate treatment satisfaction with semaglutide, a once‐weekly glucagon‐like peptide‐1 receptor agonist, versus placebo/active comparators in the SUSTAIN clinical trial programme. METHODS: In SUSTAIN 2–5 and 7, the Diabetes Treatment Satisfaction Questionnaire was used to evaluate patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Jendle, Johan, Birkenfeld, Andreas L., Polonsky, William H., Silver, Robert, Uusinarkaus, Kari, Hansen, Thomas, Håkan‐Bloch, Jonas, Tadayon, Sayeh, Davies, Melanie J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771774/
https://www.ncbi.nlm.nih.gov/pubmed/31215727
http://dx.doi.org/10.1111/dom.13816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771774/
https://www.ncbi.nlm.nih.gov/pubmed/31215727
http://dx.doi.org/10.1111/dom.13816

Ejemplares similares